← Open Payments lookup

HONG-HANH NGUYEN: Open Payments

NPI 1760021752 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,198 in 73 payments from 7 companies in 2025. Trend: 2023 $358 · 2024 $1,132 · 2025 $3,198

Food & beverage: $2,698Speaker / faculty: $500
CompanyPaymentsAmount
Madrigal Pharmaceuticals28$1,307
Gilead Sciences, Inc.17$763
Ipsen Biopharmaceuticals, Inc4$565
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$407
ABBVIE INC.2$69
ORPHALAN INC2$62
Novo Nordisk Inc1$24

Products named: REZDIFFRA, IQIRVO, XIFAXAN, CUVRIOR, MAVYRET, Wegovy, CREON.

Industry payments across TX — which companies pay providers there.